Update on tic disorders and Tourette syndrome

Paediatrics and Child Health

Volumn 20, Issue 9, 2010, Pages 411-415

  Stern, Jeremy ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Deep brain stimulation methods; Dopamine antagonists therapeutic use; Tic disorders epidemiology; Tourette syndrome diagnosis; Tourette syndrome therapy

Indexed keywords

ARIPIPRAZOLE; ATOMOXETINE; BOTULINUM TOXIN; CLOMIPRAMINE; CLONIDINE; DEXAMPHETAMINE; HALOPERIDOL; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; PIMOZIDE; QUETIAPINE; RISPERIDONE; SERTRALINE; SULPIRIDE; TETRABENAZINE; TOPIRAMATE;

ATTENTION DEFICIT DISORDER; BEHAVIOR THEORY; BRAIN DEPTH STIMULATION; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GENETIC ANALYSIS; GILLES DE LA TOURETTE SYNDROME; HUMAN; NEUROBIOLOGY; NEUROIMAGING; OBSESSIVE COMPULSIVE DISORDER; PHYSICAL EXAMINATION; PROGNOSIS; REVIEW; TIC;

EID: 77956845550     PISSN: 17517222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.paed.2010.03.013     Document Type: Review

References (14)

1. Bloch M.H., Panza K.E., Landeros-Weisenberger A., Leckman J.F. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry 2009 Sep, 48:884-893.
2. Cavanna A.E., Schrag A., Morley D., et al. The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation. Neurology 2008 Oct 28, 71:1410-1416.
3. Kataoka Y, Kalanithi PS, Grantz H, et al. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J Comp Neurol 2010 Feb 1;518: 277-91.
4. Khalifa N., von Knorring A.L. Psychopathology in a Swedish population of school children with tic disorders. J Am Acad Child Adolesc Psychiatry 2006 Nov, 45:1346-1353.
5. Martino D., Dale R.C., Gilbert D.L., Giovannoni G., Leckman J.F. Immunopathogenic mechanisms in Tourette syndrome: a critical review. Mov Disord 2009 Jul 15, 24:1267-1279.
6. Mink J.W., Walkup J., Frey K.A., et al. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord 2006 Nov, 21:1831-1838.
7. O'Rourke J.A., Scharf J.M., Yu D., Pauls D.L. The genetics of Tourette syndrome: a review. J Psychosom Res 2009, 67:533-545.
8. Plessen K.J., Bansal R., Peterson B.S. Imaging evidence for anatomical disturbances and neuroplastic compensation in persons with Tourette syndrome. J Psychosom Res 2009, 67:559-573.
9. Porta M., Brambilla A., Cavanna A.E., et al. Thalamic deep brain stimulation for treatment-refractory Tourette syndrome: two-year outcome. Neurology 2009, 27:1375-1380.
10. Rickards H. Functional neuroimaging in Tourette syndrome. J Psychosom Res 2009, 67:575-584.
11. Robertson M.M. Tourette syndrome, associated conditions and the complexities of treatment. Brain 2000 Mar, 123:425-462.
12. Robertson M.M. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res 2008 Nov, 65:461-472.
13. Spencer T.J., Sallee F.R., Gilbert D.L., et al. Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. J Atten Disord 2008 Jan, 11:470-481.
14. Genome scan for Tourette disorder in affected-sibling-pair and multigenerational families. Am J Hum Genet 2007 Feb, 80:265-272. Tourette Syndrome Association International Consortium for Genetics.